Pigment Cell & Melanoma Research

Article	Citations
An update on Vitiligo pathogenesis	67
Management of hyperpigmentation: Current treatments and emerging therapies	62
The evolution of human skin pigmentation involved the interactions of genetic, environmental, and cultural variables	46
Chemical and biochemical control of skin pigmentation with special emphasis on mixed melanogenesis	43
Participation of keratinocyte‐ and fibroblast‐derived factors in melanocyte homeostasis, the response to UV, and pigmentary disorders	39
Genetics of non‐syndromic and syndromic oculocutaneous albinism in human and mouse	35
Nicotinamide N‐methyltransferase gene silencing enhances chemosensitivity of melanoma cell lines	33
The α‐melanocyte‐stimulating hormone/melanocortin‐1 receptor interaction: A driver of pleiotropic effects beyond pigmentation	33
Alterations of the pigmentation system in the aging process	32
The fate of melanocyte: Mechanisms of cell death in vitiligo	32
The role of ferroptosis in melanoma	31
First‐line atezolizumab monotherapy in patients with advanced BRAFV600 wild‐type melanoma	23
Identification of melanoma‐specific exosomal miRNAs as the potential biomarker for canine oral melanoma	22
Dark cyclobutane pyrimidine dimers are formed in the epidermis of Fitzpatrick skin types I/II and VI in vivo after exposure to solar‐simulated radiation	22
The structure and function of the mouse tyrosinase locus	22
Artificial intelligence and melanoma: A comprehensive review of clinical, dermoscopic, and histologic applications	20
Support for increased cardiovascular risk in non‐segmental vitiligo among Egyptians: A hospital‐based, case–control study	20
NRF2‐dependent stress defense in tumor antioxidant control and immune evasion	20
Altered expression of ferroptosis markers and iron metabolism reveals a potential role of ferroptosis in vitiligo	19
A Focused review on the pathophysiology of post‐inflammatory hyperpigmentation	19
Reconstructed human pigmented skin/epidermis models achieve epidermal pigmentation through melanocore transfer	18
Circadian clock protein BMAL1 regulates melanogenesis through MITF in melanoma cells	18
Human TYRP1: Two functions for a single gene?	17
Vitiligo: Translational research and effective therapeutic strategies	17
Dhh‐expressing Schwann cell precursors contribute to skin and cochlear melanocytes, but not to vestibular melanocytes	16

HPS11 and OCA8: Two new types of albinism associated with mutations in BLOC1S5 and DCT genes	16
The MITF regulatory network in melanoma	15
The AMP‐dependent kinase pathway is upregulated in BAP1 mutant uveal melanoma	14
The unfolded protein and integrated stress response in melanoma and vitiligo	14
The role of melanocytes in the human choroidal microenvironment and inflammation: Insights from the transcriptome	14
YAP facilitates melanoma migration through regulation of actin‐related protein 2/3 complex subunit 5 (ARPC5)	14
Connecting the dots: Melanoma cell of origin, tumor cell plasticity, trans‐differentiation, and drug resistance	13
New insights into the pathogenesis of Hermansky–Pudlak syndrome	13
Tape stripping and lipidomics reveal skin surface lipid abnormity in female melasma	12
Phenotypic plasticity of melanocytes derived from human adult skin	11
Consideration of possible effects of vitamin D on established cancer, with reference to malignant melanoma	11
Drosophila yellow‐h encodes dopaminechrome tautomerase: A new enzyme in the eumelanin biosynthetic pathway	11
RASGRF2 gene fusions identified in a variety of melanocytic lesions with distinct morphological features	11
A Phase 1 study of ADI‐PEG20 (pegargiminase) combined with cisplatin and pemetrexed in ASS1‐negative metastatic uveal melanoma	11
The metabolism of melanin synthesis—From melanocytes to melanoma	10
The delicate relation between melanocytes and skin immunity: A game of hide and seek	10
5,6‐Dihydroxyindole eumelanin content in human skin with varying degrees of constitutive pigmentation	10
Multiple desmoplastic Spitz nevi with BRAF fusions in a patient with ring chromosome 7 syndrome	10
Acral lentiginous melanoma—Population, treatment, and survival using the NCDB from 2004 to 2015	10
Systematic review and meta‐analysis of genomic alterations in acral melanoma	9
The impaired unfolded protein‐premelanosome protein and transient receptor potential channels‐autophagy axes in apoptotic melanocytes in vitiligo	9
Eosinophils and melanoma: Implications for immunotherapy	9
The feather pattern autosomal barring in chicken is strongly associated with segregation at the MC1R locus	9
Connexins in melanoma: Potential role of Cx46 in its aggressiveness	9
Transcriptomic analysis and ednrb expression in cochlear intermediate cells reveal developmental differences between inner ear and skin melanocytes	9
Presence and the roles of IL‐9/Th9 axis in vitiligo	8
Recurrent co‐alteration of HDGF and SETDB1 on chromosome 1q drives cutaneous melanoma progression and poor prognosis	8
Investigating DNA methylation as a potential mediator between pigmentation genes, pigmentary traits and skin cancer	8
Volar location and degree of pigmentation are associated with poor survival and first metastasis pattern in acral melanoma	8
A B‐cell or a key player? The different roles of B‐cells and antibodies in melanoma	7
The impact of BRAF mutation status on clinical outcomes with anti‐PD‐1 monotherapy versus combination ipilimumab/nivolumab in treatment‐naïve advanced stage melanoma	7
Landscape of mutations in early stage primary cutaneous melanoma: An InterMEL study	7
A novel BLOC1S5‐related HPS‐11 patient and zebrafish with bloc1s5 disruption	6
Let’s talk about sex: A biological variable in immune response against melanoma	6
Advancements in melanoma cancer metastasis models	6
Melanoma central nervous system metastases: An update to approaches, challenges, and opportunities	6
Establishment of cultured primary acral melanoma cells and animal models for Chinese patients	5
Ulcerated melanoma: Systems biology evidence of inflammatory imbalance towards pro‐tumourigenicity	5
Interferon‐gamma induces melanogenesis via post‐translational regulation of tyrosinase	5
Increased anti‐oxidative action compensates for collagen tissue degeneration in vitiligo dermis	5
Non‐Steroidal Anti‐Inflammatory Drugs (NSAIDs) sensitize melanoma cells to MEK inhibition and inhibit metastasis and relapse by inducing degradation of AXL	5
Pharmacologic manipulation of skin pigmentation	5
Melanoma and subcutaneous adipose tissue: Role of peritumoral adipokines in disease characterization and prognosis	4
NR2F1 regulates a Schwann cell precursor‐vs‐melanocyte cell fate switch in a mouse model of Waardenburg syndrome type IV	4
Genetic and phenotypic heterogeneity of multiple lentigines and precise diagnosis in four Chinese families with multiple lentigines	4
Nrf2 protein in melanoma progression, as a new means of treatment	4
Image analysis systems to calculate the surface area of vitiligo lesions: A systematic review of measurement properties	4
Myron Gordon Award paper: Microbes, T‐cell diversity and pigmentation	4
Neratinib kills B‐RAF V600E melanoma via ROS‐dependent autophagosome formation and death receptor signaling	4
Impact of a SLC24A5 variant on the retinal pigment epithelium of a Japanese patient with oculocutaneous albinism type 6	4

Varicella‐zoster virus in actively spreading segmental vitiligo skin: Pathological, immunochemical, and ultrastructural findings (a first and preliminary study)	4
Induced pluripotent stem cells reprogramming overcomes technical limitations for highly pigmented adult melanocyte amplification and integration in 3D skin model	4
Unveiling the mystery of Riehl's melanosis: An update from pathogenesis, diagnosis to treatment	4
Influence of germline genetic variants on dermoscopic features of melanoma	4
Neutrophil‐to‐eosinophil ratio as a biomarker for clinical outcomes in advanced stage melanoma patients treated with anti‐PD‐1 therapy	4
Germline variants in exonic regions have limited impact on immune checkpoint blockade clinical outcomes in advanced melanoma	4
Transient activation of tumoral DNA damage tolerance pathway coupled with immune checkpoint blockade exerts durable tumor regression in mouse melanoma	4
Trained immunity in the pathogenesis of vitiligo	4
BMI1 is required for melanocyte stem cell maintenance and hair pigmentation	4
A prospective observational study to sequentially determine the dermoscopic features of vitiligo and its association with disease activity in patients on medical treatment	4
A twenty year perspective on melanoma therapy	4
Perspectives on the nanocarriers with miRNAs for targeting melanoma stemness through epigenetic regulation	3
Intragenic NF1 deletions in sinonasal mucosal malignant melanoma	3
Abstracts	3
Generation of Pmel‐dependent conditional and inducible Cre‐driver mouse line for melanocytic‐targeted gene manipulation	3
	3
Retrospective review of outcomes associated with metastatic melanoma patients treated with 1st‐line BRAF‐targeted therapy	3
New insights into segmental vitiligo: A clinical and immunological comparison with nonsegmental vitiligo	3
Seasonal variation in effect of anti‐PD‐1 initiation on overall survival among patients with advanced melanoma	3
Molecular characterization of biphenotypic epithelioid and plexiform melanoma with deep penetrating nevus‐like features	3
Melanoma toolkit for early detection for primary care providers: A pilot study	3
Cell‐intrinsic melanin fails to protect melanocytes from ultraviolet‐mutagenesis in the absence of epidermal melanin	3
Unsuspected consequences of synonymous and missense variants in OCA2 can be detected in blood cell RNA samples of patients with albinism	3
Toxicity and response to ipilimumab and nivolumab in older patients with metastatic melanoma: A multicentre retrospective analysis	3
The 20th International Congress of the Society for Melanoma Research	3
B7‐H3 drives immunosuppression and Co‐targeting with CD47 is a new therapeutic strategy in β‐catenin activated melanomas	3
Making a melanoma: Molecular and cellular changes underlying melanoma initiation	3
Genetic predisposition to long telomeres is associated with increased mortality after melanoma: A study of 2101 melanoma patients from hospital clinics and the general population	3
MITF deficiency and oncogenic GNAQ each promote proliferation programs in zebrafish melanocyte lineage cells	3
Dysbiosis of skin microbiome in melasma patients	3
Overview of current melanoma therapies	2
Dynamic regulation of chromatin accessibility during melanocyte stem cell activation	2
Clinical and pathological characteristics of familial melanoma with germline TERT promoter variants	2
Melanoma literacy among the general population of three western US states	2
Undereducation is afoot: Assessing the lack of acral lentiginous melanoma educational materials for skin of color	2
Immune signatures in cutaneous melanoma correlate with survival independently of immunotherapy treatment	2
	2
Uric acid is a major chemical constituent for the whitish coloration in the medaka leucophores	2
19th International Congress of the Society for Melanoma Research	2
MITF E318K: A rare homozygous case with multiple primary melanoma	2
The immunosuppressive role of Edn3 overexpression in the melanoma microenvironment	2
Establishment and characterization of an immortalized human giant congenital melanocytic nevi cell line	2
Histopathologic abundance of pigmentation correlates with disease‐specific survival in malignant melanoma but is not independent of current AJCC pT stage	2
B6‐Dct‐H2BGFP bitransgenic mice: A standardized mouse model for in vivo characterization of melanocyte development and stem cell differentiation	2
ToF‐SIMS imaging reveals changes in tumor cell lipids during metastatic progression of melanoma	2
Protein‐based classification of melanoma differentiation subtypes	2
Epigenetic and pharmacological control of pigmentation via Bromodomain Protein 9 (BRD9)	2
Leptomeningeal disease in melanoma: An update on the developments in pathophysiology and clinical care	2
Oncogenic properties via MAPK signaling of the SOX5‐RAF1 fusion gene identified in a wild‐typeNRAS/BRAF giant congenital nevus	1
Single‐cell profiling of MC1R‐inhibited melanocytes	1
	1
Zebrafish as a new model for rhododendrol‐induced leukoderma	1
Vitiligo non‐responding lesions to narrow band UVB have intriguing cellular and molecular abnormalities that may prevent epidermal repigmentation	1
Characterization of PRAME immunohistochemistry reveals lower expression in pediatric melanoma compared to adult melanoma	1
Diversity, equity, and inclusion in the melanoma research community	1
The MFSD12 p.Tyr182His common variant is sufficient to alter mouse agouti coat color	1
Journey through the spectacular landscape of melanocortin 1 receptor	1
Identification and functional assays of single‐nucleotide variants of opsins genes in melanocytic tumors	1
Genetic analysis of multiple primary melanomas arising within the boundaries of congenital nevi depigmentosa	1
Melanoma in infants, caused by a gene fusion involving the anaplastic lymphoma kinase (ALK)	1
	1
Anti‐melanogenic effect of exosomes derived from human dermal fibroblasts (BJ‐5ta‐Ex) in C57BL/6 mice and B16F10 melanoma cells	1
Review: Are moles senescent?	1
Clinicopathological features and associations in a series of South African acral melanomas	1
Modeling of pigmentation disorders associated with MITF mutation in Waardenburg syndrome revealed an impaired melanogenesis pathway in iPS‐derived melanocytes	1
Midkine—A potential therapeutic target in melanoma	1
RNA M6A modification shaping cutaneous melanoma tumor microenvironment and predicting immunotherapy response	1
Molecular heterogeneity of quiescent melanocyte stem cells revealed by single‐cell RNA‐sequencing	1
Two novel CreERT2 transgenic mouse lines to study melanocytic cells in vivo	1
Emerging therapeutic strategies for metastatic uveal melanoma: Targeting driver mutations	1
Prognostic biomarkers for survival in mucosal melanoma	1
How a membrane transporter keeps melanocytes in the red	1
Beyond the 5‐year milestone: Long‐term survivorship of melanoma patients treated off‐trial with anti‐PD‐1	1
Optimisation of skin phototype classification	1
Immune‐modulatory effects of lenalidomide inhibited the progression of lesions in a vitiligo mouse model	1
The role of dacarbazine and temozolomide therapy after treatment with immune checkpoint inhibitors in malignant melanoma patients: A case series and meta‐analysis	1
Clinicopathological features, current status, and progress of primary central nervous system melanoma diagnosis and treatment	1
MitoCur‐1 induces ferroptosis to reverse vemurafenib resistance in melanoma through inhibition of USP14	1
AP‐3 complex subunit delta gene, ap3d1, regulates melanogenesis and melanophore survival via autophagy in zebrafish (Danio rerio)	1
CD52 mRNA expression predicts prognosis and response to immune checkpoint blockade in melanoma	1

Special issue: “Biology of skin pigmentation and pigmentary diseases”	1
Proceedings from the Melanoma Research Foundation Mucosal Melanoma Meeting (December 16, 2022, New York, USA)	1
Small extracellular vesicle‐based human melanocyte and melanoma signature	1
Molecular skin fluorescence imaging: A tool for evaluating early melanoma development	1
BET inhibition sensitizes innate checkpoint inhibitor resistant melanoma to anti‐CTLA‐4 treatment	1
Senescent no more	1
The effect of oxidative degradation of Dopa‐melanin on its basic physicochemical properties and photoreactivity	1
Genotypic spectrum of albinism in Mali	1